XML 122 R34.htm IDEA: XBRL DOCUMENT v3.25.2
Share-based compensation (Tables)
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of outstanding stock options

Below is a table that summarizes the key information regarding the Plan:

 

  

Number of

options

  

Weighted average

exercise price

  

Weighted average

remaining contractual

term (Years)

  

Aggregate

intrinsic value

 
Outstanding as of January 1, 2024   586,923   4.84    6.53   67,596 
Granted   587,650    2.87    9.50    - 
Vested and exercised   -    -    -    - 
Cancelled or forfeited   (204,265)   5.94    -    - 
Outstanding as of December 31, 2024   970,308   3.65    8.75   706,366 
Exercisable as of December 31, 2024   514,210   4.13    8.23   199,667 
Outstanding, expected to vest as of December 31, 2024   456,098   3.10    9.33   506,699 
                     
Outstanding as of January 1, 2025   970,308   3.65    8.75   706,366 
Granted   495,507    3.83    9.93    - 
Vested and exercised   -    -    -    - 
Cancelled or forfeited   -    -    -    - 
Outstanding as of June 30, 2025   1,465,815   3.40    8.82   634,066 
Exercisable as of June 30, 2025   662,291   3.56    7.98   270,230 
Outstanding, expected to vest as of June 30, 2025   803,524   3.27    9.51   363,835 
Schedule of share based compensation expenses

The Company’s share-based compensation expense for the period ended June 30, 2025, and June 30, 2024, is represented by the following table:

 

   2025   2024 
   Year ended June 30 
   2025   2024 
(in Euros)          
Research & development expense  82,369   37,173 
Research & development expense - related party   39,806    - 
General & administrative expense   68,449    114,219 
General & administrative expense - related party   161,740    81,376 
Total  352,364   232,768 
Unrecognized expense  2,652,303   747,043